SCHEMBL4678773

SCHEMBL4678773

CC(C)(C(=O)O)c1cccc2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.53
ALDH1A1 P00352 2/20 0.53
HSD17B10 Q99714 1/20 0.53
ACP3 P15309 1/20 0.49
NR4A1 P22736 1/20 0.47
NR4A2 P43354 1/20 0.47
NR4A3 Q92570 1/20 0.47
PPARG P37231 3/20 0.45
PPARA Q07869 3/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
PPARD Q03181 1/20 0.45
TDP1 Q9NUW8 2/20 0.43
KIF11 P52732 1/20 0.42
CDC25B P30305 1/20 0.42
PLK1 P53350 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
SLC22A12 Q96S37 1/20 0.40
SSTR4 P31391 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7287554 0.85 KDM4E (0.53) KDM4EALDH1A1HSD17B10ACP3NR4A1
SCHEMBL4592424 0.85 KDM4E (0.53) KDM4EALDH1A1HSD17B10ACP3NR4A1
SCHEMBL12260673 0.84 ACP3 (0.60) KDM4EALDH1A1HSD17B10ACP3NR4A1
SCHEMBL31602274 0.83 KMT2A (0.50) KDM4EALDH1A1HSD17B10ACP3NR4A1
SCHEMBL668729 0.83 KDM4E (0.51) KDM4EALDH1A1HSD17B10ACP3NR4A1
SCHEMBL31602273 0.83 KMT2A (0.50) KDM4EALDH1A1HSD17B10ACP3NR4A1
SCHEMBL29608063 0.81 KDM4E (0.50) KDM4EALDH1A1HSD17B10ACP3NR4A1
SCHEMBL146376 0.81 KDM4E (0.50) KDM4EALDH1A1HSD17B10ACP3NR4A1
SCHEMBL29081148 0.81 KDM4E (0.50) KDM4EALDH1A1HSD17B10ACP3NR4A1
SCHEMBL198219 0.81 KDM4E (0.50) KDM4EALDH1A1HSD17B10ACP3NR4A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022268066-A1 PROTEIN DEGRADATION AGENT 苏州开拓药业股份有限公司 2022-12-29 WO disclosed
US-9927708-B2 Pattern forming process and shrink agent SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-03-27 US disclosed
US-9927708-B2 Pattern forming process and shrink agent SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-03-27 US disclosed
US-9632415-B2 Pattern forming process and shrink agent SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-04-25 US disclosed
US-9632415-B2 Pattern forming process and shrink agent SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-04-25 US disclosed
US-9618850-B2 Pattern forming process and shrink agent SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-04-11 US disclosed
US-9618850-B2 Pattern forming process and shrink agent SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-04-11 US disclosed
US-9436093-B2 Pattern forming process and shrink agent SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-09-06 US disclosed
US-9436093-B2 Pattern forming process and shrink agent SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-09-06 US disclosed
US-9399645-B2 Inhibitors of HIV replication BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2016-07-26 US disclosed
CN-101077875-B Boronic ester and acid compounds, synthesis and uses MILLENNIUM PHARM INC 2011-01-26 CN disclosed
EP-1045836-B1 PYRIDONES AS SRC FAMILY SH2 DOMAIN INHIBITORS BOEHRINGER INGELHEIM PHARMA (US) 2008-03-05 EP disclosed
CN-101077875-A Boronic ester and acid compounds, synthesis and uses MILLENNIUM PHARM INC (US) 2007-11-28 CN disclosed
CN-1305475-C Boronic ester and acid compounds, their synthesis and use PROSCRIPT INC (US) 2007-03-21 CN disclosed
US-6284768-B1 Src family SH2 domain inhibitors BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2001-09-04 US disclosed
US-6268365-B1 Src family SH2 domain inhibitors BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2001-07-31 US disclosed
EP-1045836-A1 PYRIDONES AS SRC FAMILY SH2 DOMAIN INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2000-10-25 EP disclosed
US-6054470-A Src family SH2 domain inhibitors BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2000-04-25 US disclosed
WO-1999031066-A1 PYRIDONES AS SRC FAMILY SH2 DOMAIN INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1999-06-24 WO disclosed
EP-0278158-A2 Renin inhibitors containing phenylalanyl-histidine replacements MERCK & CO. INC. (US) 1988-08-17 EP disclosed